Srb7 inhibitors represent a class of compounds designed to modulate the activity of Srb7, a key component of the Mediator complex. The Mediator complex is crucial in regulating gene transcription by serving as a bridge between transcription factors and RNA polymerase II. Srb7, specifically, plays an essential role in stabilizing the overall structure of the Mediator complex, ensuring its proper assembly and function. Inhibition of Srb7 can disrupt this structural integrity, potentially leading to alterations in transcriptional regulation. Given the centrality of Mediator in the transcription process, Srb7 inhibitors can interfere with the recruitment of RNA polymerase II to promoter regions of genes, thereby affecting gene expression patterns.
The mechanism by which Srb7 inhibitors function generally involves the disruption of Srb7's interaction with other components of the Mediator complex, either through competitive binding or structural interference. This inhibition can lead to a reduction in transcriptional efficiency, as the communication between transcription factors and RNA polymerase II becomes compromised. Moreover, Srb7 is also known to be involved in coordinating various cellular signals that influence transcription, so inhibitors targeting Srb7 can have broad effects on gene expression in response to environmental or cellular cues. The ability to specifically modulate Srb7's activity provides valuable insights into transcriptional regulation mechanisms and helps to further understand the detailed dynamics of the Mediator complex and its role in gene expression.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA polymerase II transcription, potentially impacting mediator complex function including Srb7. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II phosphorylation, potentially affecting Srb7's role in transcription. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Inhibits cyclin-dependent kinases, affecting transcription regulation and potentially influencing Srb7. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, potentially affecting mediator complex functions involving Srb7. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, potentially altering transcription processes involving Srb7. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Inhibits eukaryotic initiation factor 4A, indirectly affecting transcription and possibly Srb7. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Inhibits BET bromodomains, potentially influencing transcription factors and mediator complex including Srb7. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
BET bromodomain inhibitor, could alter transcriptional regulation affecting Srb7's role. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $62.00 $87.00 | 4 | |
Aurora kinase inhibitor, can indirectly affect transcriptional regulation and Srb7 function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits protein synthesis, potentially influencing cellular processes including Srb7 function. | ||||||